Gilead Sciences (GILD) News Today → World’s biggest multibillionaire investor is buying THIS by the ton [picture] (From Stansberry Research) (Ad) Free gild Stock Alerts $65.27 -1.81 (-2.70%) (As of 05:44 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineGilead Sciences (NASDAQ:GILD) Updates FY 2024 Earnings Guidancemarketbeat.com - April 25 at 5:47 PMGilead Sciences Inc (GILD) Q1 2024 Earnings: Misses Analyst EPS Estimates Amid Significant ...gurufocus.com - April 25 at 5:04 PMGilead posts quarterly loss, revenue rises 5%reuters.com - April 25 at 4:11 PMGilead Sciences Announces First Quarter 2024 Financial Resultsbusinesswire.com - April 25 at 4:02 PMGilead Sciences (NASDAQ:GILD) Reaches New 12-Month Low at $65.61marketbeat.com - April 25 at 3:45 PMGilead Sciences Target of Unusually Large Options Trading (NASDAQ:GILD)marketbeat.com - April 25 at 1:11 PMAlaska Permanent Fund Corp Sells 25,031 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)marketbeat.com - April 25 at 10:02 AMQ1 2024 EPS Estimates for Gilead Sciences, Inc. (NASDAQ:GILD) Decreased by Analystmarketbeat.com - April 25 at 7:37 AMGilead Sciences (NASDAQ:GILD) Upgraded to "Hold" at HSBCamericanbankingnews.com - April 25 at 6:15 AMFY2024 EPS Estimates for Gilead Sciences, Inc. Decreased by Analyst (NASDAQ:GILD)americanbankingnews.com - April 25 at 4:02 AMGilead Sciences, Inc. (NASDAQ:GILD) Forecasted to Post Q2 2024 Earnings of $1.40 Per Shareamericanbankingnews.com - April 25 at 2:30 AMBailard Inc. Sells 48,838 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)marketbeat.com - April 24 at 11:39 PMGilead Sciences Q1 Preview: HIV pipeline, FY24 guidance in focusmsn.com - April 24 at 6:37 PMHSBC Upgrades Gilead Sciences (NASDAQ:GILD) to "Hold"marketbeat.com - April 24 at 1:57 PMFY2024 EPS Estimates for Gilead Sciences, Inc. Reduced by Cantor Fitzgerald (NASDAQ:GILD)marketbeat.com - April 24 at 6:32 AMGilead Q1 Earnings Preview: Most Gains Wiped Out - Cause For Concern?seekingalpha.com - April 23 at 11:02 AMSigma Planning Corp Sells 22,684 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)marketbeat.com - April 23 at 6:49 AMIllinois Municipal Retirement Fund Sells 79,102 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)marketbeat.com - April 22 at 10:22 PMUndervalued Icons: 3 Household Names Trading at Steep Discountsinvestorplace.com - April 22 at 2:19 PMGilead Sciences: Some Signs Of An Impending Bottomseekingalpha.com - April 22 at 2:12 PMFoundry Partners LLC Decreases Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)marketbeat.com - April 21 at 10:35 PMGilead Sciences (NASDAQ:GILD) Stock Rating Reaffirmed by Oppenheimeramericanbankingnews.com - April 21 at 5:22 AMGilead Sciences (NASDAQ:GILD) Stock Rating Lowered by StockNews.comamericanbankingnews.com - April 21 at 1:34 AMabrdn plc Raises Position in Gilead Sciences, Inc. (NASDAQ:GILD)marketbeat.com - April 20 at 12:10 PMFDA Mandates "Boxed Warning" For Bristol Myers, Johnson & Johnson CAR-T-Based Blood Cancer Therapiesmsn.com - April 20 at 2:23 AMGilead Sciences (NASDAQ:GILD) Rating Lowered to Buy at StockNews.commarketbeat.com - April 19 at 11:04 PMXponance Inc. Increases Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)marketbeat.com - April 19 at 10:17 AMGilead Sciences (NASDAQ:GILD) Sets New 52-Week Low on Analyst Downgradeamericanbankingnews.com - April 19 at 5:36 AMGilead Sciences (NASDAQ:GILD) PT Lowered to $75.00americanbankingnews.com - April 19 at 2:36 AMGilead Sciences Publishes 2023 ESG Impact Reportfinance.yahoo.com - April 18 at 5:59 PMHold Rating on Gilead Sciences Amidst Q1 Revenue Shortfall and Acquisition Concernsmarkets.businessinsider.com - April 18 at 12:59 PMFederated Hermes Inc. Grows Position in Gilead Sciences, Inc. (NASDAQ:GILD)marketbeat.com - April 18 at 12:21 PMUBS Group Lowers Gilead Sciences (NASDAQ:GILD) Price Target to $75.00marketbeat.com - April 18 at 8:23 AMGilead Sciences (GILD) to Release Earnings on Thursdayamericanbankingnews.com - April 18 at 2:32 AMGoodman Advisory Group LLC Sells 17,821 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)marketbeat.com - April 17 at 12:48 PMGilead Sciences (NASDAQ:GILD) Sets New 1-Year Low at $67.15marketbeat.com - April 17 at 10:51 AMGILEAD SCIENCES JOIN FORCES WITH WORLD HEPATITIS ALLIANCE AND EXPERTS TO AWARD US$4 MILLION ALL4LIVER GRANT FOR VIRAL HEPATITIS ELIMINATION BY 2030, INCLUDING TWO INNOVATIVE INITIATIVES IN ASIAfinance.yahoo.com - April 17 at 7:58 AMHealthInvest Partners AB Makes New Investment in Gilead Sciences, Inc. (NASDAQ:GILD)marketbeat.com - April 16 at 6:41 PMBourgeon Capital Management LLC Sells 71,313 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)marketbeat.com - April 15 at 3:00 PMShould You Buy the 3 Highest-Paying Dividend Stocks in the Nasdaq?fool.com - April 15 at 8:00 AMGILEAD SCIENCES JOIN FORCES WITH WORLD HEPATITIS ALLIANCE AND EXPERTS TO AWARD US$4 MILLION ALL4LIVER GRANT FOR VIRAL HEPATITIS ELIMINATION BY 2030, INCLUDING TWO COMMUNITY LED INITIATIVES IN HONG KONGfinance.yahoo.com - April 15 at 2:50 AMGILEAD SCIENCES JOIN FORCES WITH WORLD HEPATITIS ALLIANCE AND EXPERTS TO AWARD US$4 MILLION ALL4LIVER GRANT FOR VIRAL HEPATITIS ELIMINATION BY 2030, INCLUDING TWO COMMUNITY-LED INITIATIVES IN ASIAfinance.yahoo.com - April 15 at 2:50 AMGilead Sciences, Inc. (NASDAQ:GILD) Short Interest Up 17.2% in Marchmarketbeat.com - April 14 at 7:21 PMGilead Sciences, Inc. (NASDAQ:GILD) Stake Lessened by Conning Inc.marketbeat.com - April 14 at 3:54 PMMn Services Vermogensbeheer B.V. Sells 18,900 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)marketbeat.com - April 13 at 7:31 PMGilead Sciences, Inc. (NASDAQ:GILD) Shares Purchased by NewEdge Wealth LLCmarketbeat.com - April 12 at 9:03 PMGilead Sciences: Robust HIV Business and Oncology Growth Potential Justify Buy Ratingmarkets.businessinsider.com - April 11 at 1:25 PMTop 3 Health Care Stocks Which Could Rescue Your Portfolio This Quarter - Gilead Sciences (NASDAQ:GILD), UnitedHealth Group (NYSE:UNH)benzinga.com - April 11 at 8:46 AMGilead Sciences (NASDAQ:GILD) Hits New 1-Year Low at $68.42marketbeat.com - April 10 at 2:51 PMAllspring Global Investments Holdings LLC Has $71.93 Million Stock Position in Gilead Sciences, Inc. (NASDAQ:GILD)marketbeat.com - April 10 at 7:29 AM Get Gilead Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for GILD and its competitors with MarketBeat's FREE daily newsletter. Email Address Better than Bitcoin? The Biotech Stock with 46,751% Potential (Ad)4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December. Get the name of the stock here >>> GILD Media Mentions By Week GILD Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GILD News Sentiment▼0.290.41▲Average Medical News Sentiment GILD News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GILD Articles This Week▼3416▲GILD Articles Average Week Get Gilead Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for GILD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: SGEN News Today BIIB News Today AMGN News Today MRNA News Today ARGX News Today HCA News Today GSK News Today ZTS News Today BMY News Today REGN News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GILD) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsThe World's First "$20 Trillion Drug?"Behind the MarketsThe only accurate crypto trading system I know …Weiss RatingsFed launches fourth dollar overhaulStansberry ResearchForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Gilead Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
